Patents by Inventor Saravanan Kappusamy

Saravanan Kappusamy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11746119
    Abstract: The present invention includes compound having the following structural formula:
    Type: Grant
    Filed: November 5, 2021
    Date of Patent: September 5, 2023
    Assignee: SignPath Pharma, Inc.
    Inventors: James McChesney, Annie Bouchard, Saravanan Kappusamy, John Kallikat Augustine, Daniel Emil Levy
  • Patent number: 11643424
    Abstract: The present invention includes compound having the following structural formula:
    Type: Grant
    Filed: March 3, 2021
    Date of Patent: May 9, 2023
    Assignee: SignPath Pharma, Inc.
    Inventors: James McChesney, Annie Bouchard, Saravanan Kappusamy, John Kallikat Augustine, Daniel Emil Levy
  • Publication number: 20230042703
    Abstract: The present invention includes a method of reducing or eliminating a cardiotoxic or cardiopathic effect of one or more active agents comprising: administering to a subject in need thereof an effective amount of one or more lipids that reduce or eliminate the cardiotoxic effect of the one or more active agents, wherein the lipid has formula: .
    Type: Application
    Filed: September 22, 2022
    Publication date: February 9, 2023
    Inventors: James McChesney, Annie Bouchard, Saravanan Kappusamy, John Kallikat Augustine, Daniel Emil Levy, Dany Salvail
  • Publication number: 20220056057
    Abstract: The present invention includes compound having the following structural formula:
    Type: Application
    Filed: November 5, 2021
    Publication date: February 24, 2022
    Inventors: James McChesney, Annie Bouchard, Saravanan Kappusamy, John Kallikat Augustine, Daniel Emil Levy
  • Publication number: 20210198294
    Abstract: The present invention includes compound having the following structural formula:
    Type: Application
    Filed: March 3, 2021
    Publication date: July 1, 2021
    Inventors: James McChesney, Annie Bouchard, Saravanan Kappusamy, John Kallikat Augustine, Daniel Emil Levy
  • Patent number: 10975111
    Abstract: The present invention includes compound having the following structural formula:
    Type: Grant
    Filed: June 26, 2019
    Date of Patent: April 13, 2021
    Assignee: Signpath Pharma, Inc.
    Inventors: James McChesney, Annie Bouchard, Saravanan Kappusamy, John Kallikat Augustine, Daniel Emil Levy
  • Publication number: 20190389888
    Abstract: The present invention includes compound having the following structural formula:
    Type: Application
    Filed: June 26, 2019
    Publication date: December 26, 2019
    Inventors: James McChesney, Annie Bouchard, Saravanan Kappusamy, John Kallikat Augustine, Daniel Emil Levy